PortfoliosLab logoPortfoliosLab logo

iShares U.S. Pharmaceuticals ETF (IHE) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with IHE. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to IHE

IHE charges 0.38% annually. There are 14 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.08%.


Best Risk-Adjusted Alternatives to IHE

IHE has a PortfoliosLab risk / return rank of 94. There are 3 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 96.


Top Performing IHE Alternatives (YTD)

IHE is at 18.61% YTD. There are 16 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 40.11%.


Lowest Volatility Alternatives to IHE

IHE has 18.09% 1-year volatility. There are 24 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 0.00%.


Lowest Drawdown Alternatives to IHE

IHE has a 1-year max drawdown of -8.47%. There are 4 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as 0.00%.


Other ETFs from iShares

The 10 most viewed iShares ETFs shown here include SGOV, IBIT, SOXX and span 14 categories. AUM among these funds goes as high as $894B.


Often Compared With IHE

Investors most often compare IHE with PPH, XPH, VYM. These 20 comparison targets span 9 categories, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
VanEck Pharmaceutical ETFHealth & Biotech Equities
54
6.91%
944.89MDec 2011IHE vs PPH
SPDR S&P Pharmaceuticals ETFHealth & Biotech Equities
91
19.55%
479.61MJun 2006IHE vs XPH
Vanguard High Dividend Yield ETFDividend
83
13.44%
96.10BNov 2006IHE vs VYM
Invesco Dynamic Pharmaceuticals ETFHealth & Biotech Equities
91
13.12%
357.90MJun 2005IHE vs PJP
iShares U.S. Insurance ETFFinancials Equities
46
10.65%
473.96MMay 2006IHE vs IAK
Virtus LifeSci Biotech Products ETFHealth & Biotech Equities
91
22.76%
98.34MDec 2014IHE vs BBP
Teva Pharmaceutical Industries Limited
94
3.11%
IHE vs TEVA
Direxion Daily Pharmaceutical & Medical Bull 3X Sh...Leveraged Equities
93
48.76%
25.08MNov 2017IHE vs PILL
Fidelity 500 Index FundS&P 500
63
11.06%
Feb 1988IHE vs FXAIX
Horizon Kinetics Medical ETFHealth & Biotech Equities
61
6.93%
18.92MSep 1999IHE vs MEDX
ProShares S&P 500 Dividend Aristocrats ETFDividend, S&P 500, Large Cap Value Equities
37
10.60%
11.63BOct 2013IHE vs NOBL
Jpmorgan Healthcare Leaders ETFHealth & Biotech Equities
51
4.73%
9.09MNov 2023IHE vs JDOC
Janus Henderson Global Life Sciences Fund Class THealth & Biotech Equities
88
9.90%
Dec 1998IHE vs JAGLX
Invesco S&P 500 Equal Weight Health Care ETFHealth & Biotech Equities, S&P 500, Equal Weight
39
7.48%
734.15MNov 2006IHE vs RSPH
iShares Nasdaq Biotechnology ETFHealth & Biotech Equities
85
12.41%
9.35BFeb 2001IHE vs IBB
iShares Global Healthcare ETFHealth & Biotech Equities
38
2.76%
4.08BNov 2001IHE vs IXJ
Fidelity Select Pharmaceuticals PortfolioHealth & Biotech Equities
80
14.61%
Jun 2001IHE vs FPHAX
F/m Emerald Life Sciences Innovation ETFHealth & Biotech Equities
92
23.43%
74.65MOct 2024IHE vs LFSC
Invesco QQQ ETFNasdaq-100
58
16.13%
481.14BMar 1999IHE vs QQQ
T. Rowe Price Health Care ETFHealth & Biotech Equities, Actively Managed
82
16.84%
Jun 2025IHE vs TMED

Compare IHE with Any Fund or Stock

Compare IHE with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair IHE with funds that move differently

iShares U.S. Pharmaceuticals ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to IHE.

Explore IHE Diversifiers